Norris Medicines Ltd to Approve Q4 Results on February 14, 2026

Norris Medicines Ltd has announced that its Board of Directors will meet on February 14, 2026, to consider and approve the un-audited financial results for the quarter ended 31st December 2025. The meeting will be held at the company's registered office in Ankleshwar, Gujarat. The trading window for dealing in securities of the company is closed from January 01, 2026, until 48 hours after the declaration of the un-audited financial results.